Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001571049-17-004816
Filing Date
2017-05-10
Accepted
2017-05-10 16:16:16
Documents
50
Period of Report
2017-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q t1700266_10q.htm 10-Q 287880
2 EXHIBIT 31.1 t1700266_ex31-1.htm EX-31.1 9871
3 EXHIBIT 31.2 t1700266_ex31-2.htm EX-31.2 9925
4 EXHIBIT 32.1 t1700266_ex32-1.htm EX-32.1 4508
5 EXHIBIT 32.2 t1700266_ex32-2.htm EX-32.2 4636
  Complete submission text file 0001571049-17-004816.txt   2662233

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE gnvc-20170331.xml EX-101.INS 506351
7 XBRL SCHEMA FILE gnvc-20170331.xsd EX-101.SCH 34092
8 XBRL CALCULATION FILE gnvc-20170331_cal.xml EX-101.CAL 21571
9 XBRL DEFINITION FILE gnvc-20170331_def.xml EX-101.DEF 132194
10 XBRL LABEL FILE gnvc-20170331_lab.xml EX-101.LAB 284876
11 XBRL PRESENTATION FILE gnvc-20170331_pre.xml EX-101.PRE 202261
Mailing Address 910 CLOPPER ROAD SUITE 220N GAITHERSBURG MD 20878
Business Address 910 CLOPPER ROAD SUITE 220N GAITHERSBURG MD 20878 2406320740
GENVEC INC (Filer) CIK: 0000934473 (see all company filings)

EIN.: 232705690 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-24469 | Film No.: 17830456
SIC: 2834 Pharmaceutical Preparations